ANI Pharmaceuticals | ANIP - Current Assets


ANI Pharmaceuticals reported $902.82M in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
AbbVie USD 37.48B 3.81B Sep/2026
ANI Pharmaceuticals USD 902.82M 77.39M Sep/2026
Aurora Cannabis CAD 393.45M 4M Jun/2026
Canopy Growth CAD 506.36M 23.1M Jun/2026
Eli Lilly USD 65.26B 591M Sep/2026
Emergent BioSolutions USD 679.5M 41.3M Dec/2023
Heron Therapeutics USD 209.11M 20.73M Sep/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Nektar Therapeutics USD 589.04M 322.77M Mar/2026
Novartis USD 28.75B 2.14B Sep/2026
Omeros USD 69.65M 26.53M Jun/2025
Perrigo USD 2.4B 49.7M Sep/2026
Sun Pharmaceuticals INR 692.67B 54.06B Sep/2026
Teva Pharmaceutical Industries USD 14.6B 842M Sep/2026